FSHCX vs. FBDIX

Last updated Jun 24, 2026

FSHCX (Fidelity Select Health Care Services Portfolio) and FBDIX (Franklin Biotechnology Discovery Fund) are both Health & Biotech Equities funds. Over the past 10 years, FSHCX returned 9.25%/yr vs 12.16%/yr for FBDIX. A 0.52 correlation means they provide meaningful diversification when combined. FSHCX charges 0.71%/yr vs 1.06%/yr for FBDIX.

Performance

FSHCX vs. FBDIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Health Care Services Portfolio (FSHCX) and Franklin Biotechnology Discovery Fund (FBDIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with FSHCX having a 10.58% return and FBDIX slightly lower at 10.35%. Over the past 10 years, FSHCX has underperformed FBDIX with an annualized return of 9.25%, while FBDIX has yielded a comparatively higher 12.16% annualized return.

FSHCX

• 1D: 1.13%
• 1M: 6.00%
• YTD: 10.58%
• 6M: 10.93%
• 1Y: 16.00%
• 3Y*: 2.05%
• 5Y*: 1.70%
• 10Y*: 9.25%

FBDIX

• 1D: 3.32%
• 1M: 3.97%
• YTD: 10.35%
• 6M: 9.01%
• 1Y: 77.20%
• 3Y*: 30.39%
• 5Y*: 9.12%
• 10Y*: 12.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FSHCX vs. FBDIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FSHCX Fidelity Select Health Care Services Portfolio	10.58%	3.85%	-13.21%	1.52%	0.86%	20.22%	18.58%	19.91%	10.17%	24.46%
FBDIX Franklin Biotechnology Discovery Fund	10.35%	52.68%	15.37%	18.40%	-12.65%	-27.58%	29.85%	49.11%	-15.77%	18.83%

Correlation

The correlation between FSHCX and FBDIX is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.29
Correlation (3Y) Calculated over the trailing 3-year period	0.30
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (10Y) Calculated over the trailing 10-year period	0.46
Correlation (All Time) Calculated using the full available price history since Sep 15, 1997	0.52

Over the past year, the correlation between FSHCX and FBDIX has dropped to 0.29 - well below their long-term average of 0.52, suggesting their price drivers have been diverging.

Return for Risk

FSHCX vs. FBDIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSHCX

FSHCX Risk / Return Rank: 10
FSHCX Sharpe Ratio Rank: 10
FSHCX Sortino Ratio Rank: 9
FSHCX Omega Ratio Rank: 11
FSHCX Calmar Ratio Rank: 10
FSHCX Martin Ratio Rank: 9

FBDIX

FBDIX Risk / Return Rank: 93
FBDIX Sharpe Ratio Rank: 96
FBDIX Sortino Ratio Rank: 90
FBDIX Omega Ratio Rank: 83
FBDIX Calmar Ratio Rank: 98
FBDIX Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FSHCX vs. FBDIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Health Care Services Portfolio (FSHCX) and Franklin Biotechnology Discovery Fund (FBDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FSHCX	FBDIX	Difference
Sharpe ratio: Return per unit of total volatility	0.78	3.25	-2.47
Sortino ratio: Return per unit of downside risk	1.11	4.11	-3.00
Omega ratio: Gain probability vs. loss probability	1.16	1.51	-0.35
Calmar ratio: Return relative to maximum drawdown	0.95	8.37	-7.43
Martin ratio: Return relative to average drawdown	2.40	26.22	-23.82

FSHCX vs. FBDIX - Sharpe Ratio Comparison

The current FSHCX Sharpe Ratio is 0.78, which is lower than the FBDIX Sharpe Ratio of 3.25. The chart below compares the historical Sharpe Ratios of FSHCX and FBDIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FSHCX vs. FBDIX - Drawdown Comparison

The maximum FSHCX drawdown since its inception was -57.81%, smaller than the maximum FBDIX drawdown of -71.44%. Use the drawdown chart below to compare losses from any high point for FSHCX and FBDIX.

Drawdown Indicators

	FSHCX	FBDIX	Difference
Max Drawdown Largest peak-to-trough decline	-57.81%	-71.44%	+13.63%
Max Drawdown (1Y) Largest decline over 1 year	-17.15%	-9.18%	-7.97%
Max Drawdown (3Y) Largest decline over 3 years	-29.52%	-24.22%	-5.30%
Max Drawdown (5Y) Largest decline over 5 years	-29.52%	-46.83%	+17.31%
Max Drawdown (10Y) Largest decline over 10 years	-35.48%	-53.67%	+18.19%
Current Drawdown Current decline from peak	-5.37%	-0.36%	-5.01%
Average Drawdown Average peak-to-trough decline	-11.36%	-28.70%	+17.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.75%	2.93%	+3.82%

Volatility

FSHCX vs. FBDIX - Volatility Comparison

The current volatility for Fidelity Select Health Care Services Portfolio (FSHCX) is 5.16%, while Franklin Biotechnology Discovery Fund (FBDIX) has a volatility of 8.95%. This indicates that FSHCX experiences smaller price fluctuations and is considered to be less risky than FBDIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FSHCX	FBDIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.16%	8.95%	-3.79%
Volatility (6M) Calculated over the trailing 6-month period	15.47%	18.44%	-2.97%
Volatility (1Y) Calculated over the trailing 1-year period	20.77%	23.68%	-2.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.24%	25.83%	-6.59%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.51%	26.35%	-4.84%

FSHCX vs. FBDIX - Expense Ratio Comparison

FSHCX has a 0.71% expense ratio, which is lower than FBDIX's 1.06% expense ratio.

Dividends

FSHCX vs. FBDIX - Dividend Comparison

FSHCX's dividend yield for the trailing twelve months is around 0.68%, less than FBDIX's 9.80% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBDIX Franklin Biotechnology Discovery Fund	9.80%	10.81%	19.53%	0.00%	0.13%	0.98%	14.50%	18.77%	3.72%	2.39%	4.57%	8.42%
FSHCX Fidelity Select Health Care Services Portfolio	0.68%	0.75%	16.63%	0.57%	5.32%	7.09%	0.76%	0.27%	12.92%	13.41%	4.62%	4.06%

Frequently Asked Questions

Can I hold both FSHCX and FBDIX in my portfolio?

FSHCX and FBDIX have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FSHCX or FBDIX?

FBDIX has higher volatility (8.95%) compared to FSHCX (5.16%). In terms of maximum drawdown, FSHCX dropped -57.81% vs FBDIX's -71.44%.

Which has better risk-adjusted returns?

FBDIX currently has the higher Sharpe Ratio (3.25 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.